Trial intelligence / Profile preview

Effectiveness of cilostazol in improving maturation rate of radiocephalic arteriovenous fistula in CKD stage 5

TCTR20190203002Phase 4Recruiting

Sponsor
Nakhon Pathom Hospital
Start
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of cilostazol in chronic kidney disease (CKD), sponsored by Nakhon Pathom Hospital. Started Nov 2018; status: recruiting.

02

Drugs

cilostazol
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on TCTR20190203002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190203002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call